TUMOR-MARKERS IN THE RECOGNITION AND MANAGEMENT OF POORLY DIFFERENTIATED NEOPLASMS AND CANCERS OF UNKNOWN PRIMARY

被引：0
|
作者：
RUDDON, RW
机构：
来源：
SEMINARS IN ONCOLOGY | 1982年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：416 / 426
页数：11
相关论文
共 50 条
  • [21] ROLE OF TUMOR-MARKERS IN THE MANAGEMENT OF PRIMARY INTRACRANIAL GERM-CELL TUMOR
    ARITA, N
    USHIO, Y
    HAYAKAWA, T
    BITOH, S
    MORI, S
    HASEGAWA, H
    MOGAMI, H
    NEUROSURGERY, 1986, 19 (02) : 328 - 328
  • [22] TUMOR-MARKERS AND PRIMARY SITE OF CANCER
    PINHORN, A
    BRITISH MEDICAL JOURNAL, 1993, 306 (6878): : 651 - 651
  • [23] Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: Favorable subsets of patients with unknown-primary carcinoma?
    Lenzi, R
    Hess, KR
    Abbruzzese, MC
    Raber, MN
    Ordonez, NG
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 2056 - 2066
  • [24] Evaluation of Applicability of Tumor Budding and Poorly Differentiated Clusters as Additional Prognostic Markers in Colorectal Cancers
    Sarkar, Sagarika
    Guha, Rena
    Chakrabarti, Sudipta
    SOUTH ASIAN JOURNAL OF CANCER, 2024, 13 (04) : 315 - 319
  • [25] Second neoplasms after cancers of unknown primary
    Levi, F.
    Blanc-Moya, R.
    Maspoli-Conconi, M.
    Randimbison, L.
    La Vecchia, C.
    ANNALS OF ONCOLOGY, 2011, 22 (06) : 1464 - U228
  • [26] MANAGEMENT OF SEMINOMA BASED ON TUMOR-MARKERS
    JAVADPOUR, N
    UROLOGIC CLINICS OF NORTH AMERICA, 1980, 7 (03) : 773 - 781
  • [27] TUMOR-MARKERS IN THE DIAGNOSIS OF NEOPLASMS OF THE CENTRAL NERVOUS-SYSTEM
    COLLINS, VP
    ACTA NEUROLOGICA SCANDINAVICA, 1985, 71 (01): : 79 - 79
  • [28] ROLE OF TUMOR-MARKERS IN THE MANAGEMENT OF PRIMARY INTRACRANIAL GERM-CELL TUMORS
    ARITA, N
    USHIO, Y
    HAYAKAWA, T
    MORI, S
    BITOH, S
    HASEGAWA, H
    AKAGI, K
    KANO, M
    OKU, Y
    GO, J
    TAKIMOTO, Y
    MOGAMI, H
    PROGRESS IN EXPERIMENTAL TUMOR RESEARCH, 1987, 30 : 289 - 295
  • [29] Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site
    Hainsworth, JD
    Lennington, WJ
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 632 - 635
  • [30] ROLE OF TUMOR-MARKERS IN THE DIAGNOSIS AND MANAGEMENT OF BRONCHOPULMONARY
    QUOIX, E
    REVUE DES MALADIES RESPIRATOIRES, 1994, 11 (04) : 319 - 320
12345